EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC-ND 4.0

Low incidence of de novo HLA antibodies after COVID‐19 vaccination: A cohort study of patients awaiting kidney transplantation

Ahmad Abu-Khader iD, Qian Hu, Fareed Kamar, Iwona Galaszkiewicz, Wenjie Wang, Faisal Khan, Noureddine Berka

Transplant Infectious Disease · 2023

DOI: 10.1111/tid.14105 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Transplant Infectious Disease, 2023. Verfasst von Ahmad Abu-Khader und 6 weiteren Autor:innen. Beteiligte Einrichtung: Transplant Immunology and Histocompatibility Laboratory, Department of Pathology, University of Texas Southwestern Medical Center, Texas, USA. Hauptthemen laut MEDLINE: Antibodies, Viral, COVID-19, COVID-19 Vaccines, Kidney Transplantation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Antibodies against human leukocyte antigen (anti‐HLA Abs) are associated with an increased risk of allograft loss. Herein, we report the prospective follow‐up for anti‐HLA Abs formation in 103 patients with end‐stage kidney disease on the waiting list for transplantation who underwent COVID‐19 vaccination. Patients and methods Sera were tested before and after vaccination using Luminex technology. The cohort comprised of 62 males and 41 females with a mean age of 56 ± 14 years. The patients received BNT162b2 (80.4%), mRNA‐1273 (18.5%), AZD1222 (0.40%), or ChAdOx1‐S (0.80%) vaccine. Patients were tested before and within 119 ± 50, 95 ± 46 and 25 ± 26 days after the first, second, and third dose of the vaccine, respectively.

Results

No significant change in calculated panel reactive antibody (cPRA) after vaccination was seen. Although 98.1% of patients had no change in anti‐HLA Abs profile or cPRA after vaccination, two patients (1.9%) developed de novo anti‐HLA Abs against class I or II HLA antigens. In those two patients, the cPRA changed from 0% and 63% at baseline to 9% and 90% after vaccination, respectively. Both patients received the BNT162b2 mRNA‐based vaccine. The earliest detected anti‐HLA Abs was 18 days after the first dose.

Conclusion

In rare cases, new anti‐HLA antibodies were observed after COVID‐19 vaccination, with potential implications for transplantation. The low incidence of this phenomenon is outweighed by the clinical benefits of vaccination. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, ViralCOVID-19COVID-19 VaccinesKidney TransplantationAdultAgedFemaleHumansMaleMiddle AgedBNT162 VaccineChAdOx1 nCoV-19Cohort StudiesHLA AntigensIncidenceProspective StudiesVaccination

Stichwörter der Autor:innen

COVID-19SARS Cov-2 vaccinationde novo HLA antibodieskidney transplant candidates

Substanzen

Antibodies, ViralBNT162 VaccineChAdOx1 nCoV-19COVID-19 VaccinesHLA Antigens

Autor:innen und Institutionen

  • Transplant Immunology and Histocompatibility Laboratory, Department of Pathology, University of Texas Southwestern Medical Center, Texas, USA.
  • Histocompatibility and Immunogenetics Laboratory, Alberta Precision Laboratories, Alberta, Canada.
  • Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, Alberta, Canada.
  • Department of Medicine, University of Calgary, Calgary, Alberta, Canada.

ORCID-Profile: Ahmad Abu-Khader

Zitieren

APA

Abu-Khader, A., Hu, Q., Kamar, F., Galaszkiewicz, I., Wang, W., Khan, F., & Berka, N. (2023). Low incidence of de novo HLA antibodies after COVID‐19 vaccination: A cohort study of patients awaiting kidney transplantation. Transplant Infectious Disease. https://doi.org/10.1111/tid.14105

Vancouver

Abu-Khader A, Hu Q, Kamar F, Galaszkiewicz I, Wang W, Khan F, et al. Low incidence of de novo HLA antibodies after COVID‐19 vaccination: A cohort study of patients awaiting kidney transplantation. Transplant Infectious Disease. 2023. doi:10.1111/tid.14105

BibTeX
@article{AbuKhader2023,
  author = {Abu-Khader, Ahmad and Hu, Qian and Kamar, Fareed and Galaszkiewicz, Iwona and Wang, Wenjie and Khan, Faisal and Berka, Noureddine},
  title = {Low incidence of de novo HLA antibodies after COVID‐19 vaccination: A cohort study of patients awaiting kidney transplantation},
  journal = {Transplant Infectious Disease},
  year = {2023},
  doi = {10.1111/tid.14105}
}
Kostenlos starten →